Evidence map›Paper›PMID 29521146›Full record

ArticlePharmaceutical biology2018

Desalted Salicornia europaea powder and its active constituent, trans-ferulic acid, exert anti-obesity effects by suppressing adipogenic-related factors.

Md Mahbubur Rahman, Myung-Jin Kim, Jin-Hyoung Kim, Sok-Ho Kim, Hyeon-Kyu Go, Mee-Hyang Kweon, Do-Hyung Kim

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutical biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Review
  3. Coastal halophyte plantRSC advances · 2025
    Article
  4. Article
  5. Article
  6. Inhibitory Effects of Sesquiterpenoids Isolated fromInternational journal of molecular sciences · 2023
    Article
  7. Effects of FermentedNutrients · 2023
    Article
  8. Anti-Obesity and Anti-Dyslipidemic Effects ofFoods (Basel, Switzerland) · 2023
    Article
  9. Bioactive Extracts fromPlants (Basel, Switzerland) · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Antioxidants (Basel, Switzerland) · 2021
    Article
  14. The drying process ofJournal of food science and technology · 2020
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Md Mahbubur Rahmana Research Center , KNOTUS Co. Ltd , Guri-Si , Gyeonggi-Do , Republic of Korea.
Myung-Jin Kima Research Center , KNOTUS Co. Ltd , Guri-Si , Gyeonggi-Do , Republic of Korea.
Jin-Hyoung Kima Research Center , KNOTUS Co. Ltd , Guri-Si , Gyeonggi-Do , Republic of Korea.
Sok-Ho Kimc Department of Biofood research , Knotus Life Science Inc , Jeongeup , Republic of Korea.
Hyeon-Kyu Goa Research Center , KNOTUS Co. Ltd , Guri-Si , Gyeonggi-Do , Republic of Korea.
Mee-Hyang Kweond Research Center , Phyto Corporation , Seoul , Republic of Korea.
Do-Hyung Kima Research Center , KNOTUS Co. Ltd , Guri-Si , Gyeonggi-Do , Republic of Korea.
Kangwon National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextSalicornia europaea (Amaranthaceae) (SE) has been shown to reduce obesity, but it remains a problem as a food supplement because of its high salt content (25-35% NaCl).

objectivesThis study investigated the anti-obesity effects and mechanism of action of desalted SE powder (DSP). MATERIALS AND

methodsSprague-Dawley rats (n = 50) were divided into a normal control group (NC), a high-fat diet (HFD)-induced obesity control group (HFD), and HFD groups co-administered DSP (250 and 500 mg/kg) or Garcinia cambogia (Clusiaceae) extract (GE, 200 mg/kg, standard control) orally each day for 12 weeks.

resultsThe body weight was significantly reduced by co-administration of DSP (596.51 ± 19.84 kg, 4.60% and 562.08 ± 9.74 kg, 10.10%, respectively) and GE (576.00 ± 11.29 kg, 7.88%) relative to the HFD group (625.25 ± 14.02 kg) and was accompanied by reduced abdominal fat mass, and serum lipid levels, with no effects on feed intake. To find the underlying mechanism of the anti-obesity effects, trans-ferulic acid (TFA) was identified as the main ingredient and investigated with regard to whether it attenuated adipogenesity in 3T3L-1 cells. DSP-derived TFA suppressed adipocyte differentiation and accumulation of intracellular lipids. TFA also down-regulated the adipogenesis-related gene expression of sterol regulatory element-binding protein 1, peroxisome proliferator-activated receptor γ, CCAAT/enhancer binding protein-α and fatty acid synthase.

conclusionsThese findings suggest that DSP may be considered for use as a food supplement intent of controlling obesity through its antiobesity and antiadipogenic properties.

Indexed as

Chenopodiaceae3T3-L1 CellsAdipogenesisAnimalsAnti-Obesity AgentsBody WeightCoumaric AcidsDose-Response Relationship, DrugMaleMiceObesityPlant ExtractsRatsRats, Sprague-DawleyAnti-Obesity AgentsCoumaric Acidsferulic acidPlant Extracts3T3L-1 cellsabdominal fat massadipogenesisDesaltation

Identifiers

PMID29521146
PMCPMC6130585
OpenAlexW2793728450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.